et al. reported worse prognosis in stage I. lung cancer, which indicated maintenance of RARβ expression and overexpression of RARβ correlated with increased expression of cyclooxygenase-2, an enzyme that contributes to progressive carcinogenesis and is a marker of poor prognosis [41,42]. Here, RARB is linked to lung cancer.